全文获取类型
收费全文 | 1967篇 |
免费 | 322篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 105篇 |
妇产科学 | 24篇 |
基础医学 | 147篇 |
口腔科学 | 31篇 |
临床医学 | 303篇 |
内科学 | 637篇 |
皮肤病学 | 65篇 |
神经病学 | 183篇 |
特种医学 | 285篇 |
外科学 | 290篇 |
综合类 | 31篇 |
预防医学 | 65篇 |
眼科学 | 17篇 |
药学 | 59篇 |
中国医学 | 1篇 |
肿瘤学 | 63篇 |
出版年
2024年 | 9篇 |
2023年 | 53篇 |
2022年 | 20篇 |
2021年 | 29篇 |
2020年 | 92篇 |
2019年 | 17篇 |
2018年 | 90篇 |
2017年 | 72篇 |
2016年 | 71篇 |
2015年 | 62篇 |
2014年 | 100篇 |
2013年 | 119篇 |
2012年 | 56篇 |
2011年 | 41篇 |
2010年 | 81篇 |
2009年 | 118篇 |
2008年 | 53篇 |
2007年 | 58篇 |
2006年 | 57篇 |
2005年 | 45篇 |
2004年 | 37篇 |
2003年 | 23篇 |
2002年 | 29篇 |
2001年 | 40篇 |
2000年 | 25篇 |
1999年 | 36篇 |
1998年 | 83篇 |
1997年 | 97篇 |
1996年 | 82篇 |
1995年 | 70篇 |
1994年 | 50篇 |
1993年 | 54篇 |
1992年 | 37篇 |
1991年 | 27篇 |
1990年 | 30篇 |
1989年 | 60篇 |
1988年 | 44篇 |
1987年 | 31篇 |
1986年 | 23篇 |
1985年 | 25篇 |
1984年 | 18篇 |
1983年 | 10篇 |
1982年 | 14篇 |
1981年 | 14篇 |
1980年 | 14篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 11篇 |
1971年 | 10篇 |
排序方式: 共有2330条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
The triglyceride connection in atherosclerosis. 总被引:4,自引:0,他引:4
OBJECTIVE: To examine the proposed mechanism of triglyceride-induced atherogenesis, to address the controversy surrounding serum triglycerides as a coronary heart disease (CHD) risk factor, and to recommend an appropriate therapeutic approach to hypertriglyceridemia. DATA SOURCES: Studies, review articles, and editorials published since 1976. A MEDLINE search of English-language literature was conducted using the terms triglyceride and hypertriglyceridemia. STUDY SELECTION: Studies, review articles, and editorials were selected for detailed review if they addressed the pathogenesis of triglyceride-induced atherosclerosis, the controversy associated with elevated serum triglyceride as a CHD risk factor, and hypertriglyceridemia treatment options. DATA EXTRACTION: Data were reviewed that described the atherogenicity of chylomicron and very low-density lipoprotein (VLDL) remnants, the inverse relationship that exists between high-density lipoprotein (HDL) and serum triglyceride, the hypertriglyceridemia treatment controversy, and the treatment options of diet, exercise, weight control, alcohol restriction, and medication. DATA SYNTHESIS: Hypertriglyceridemia is a well-known risk factor for pancreatitis. However, its role in atherogenesis is less well defined. Several proposed connections appear to exist between hypertriglyceridemia and atherosclerosis, including the inverse correlation between triglycerides and HDL, the presumed atherogenicity of triglyceride-rich lipoprotein remnant particles, the potential resultant increase in the serum concentration and atherogenicity of low-density lipoprotein (LDL), and the proposed interaction between serum triglyceride and the fibrinolytic/coagulation system. Clinical trials addressing this issue offer mixed results that are subject to interpretation. Diet, exercise, weight control, alcohol restriction, and certain lipid-lowering medications are effective at reducing serum triglyceride. CONCLUSIONS: Hypertriglyceridemia is a theoretical risk factor for CHD because of the increased production of atherogenic chylomicron and VLDL remnants, the inverse relationship present between serum triglyceride and HDL, the possible resultant increase in LDL attributable to remnant-reduced hepatic LDL-receptors as well as the formation of more dense and, therefore, more atherogenic LDL, and to the interaction between serum triglyceride and the fibrinolytic/coagulation system. However, most clinical trials that have found hypertriglyceridemia to be a risk factor for CHD do not include other CHD risk factors in their analyses. Therapeutic intervention to lower serum triglyceride with diet, exercise, and/or drugs is definitely recommended in the treatment and/or prevention of pancreatitis; however, the role of triglyceride-lowering to reduce CHD risk remains controversial. 相似文献
9.
Endoscopic retrograde cholangiopancreatography in the preoperative diagnosis of pancreatic neoplasms associated with cysts 总被引:1,自引:0,他引:1
Neither computed tomography (CT) nor ultrasonography reliably distinguishes neoplastic from non-neoplastic pancreatic cysts. More invasive tests such as angiography or biopsy fail to differentiate these lesions in up to a third of patients. Because appropriate treatment differs greatly for these two classes of lesions, the clinician requires a more accurate means of confirming or excluding neoplasia. In an effort to refine the preoperative diagnosis of pancreatic cysts and evaluate the utility of endoscopic retrograde pancreatography (ERCP), we evaluated 11 patients with proven pancreatic neoplasia associated with cysts who underwent preoperative ERCP and CT scanning. Four patients had microcystic cystadenomas, two had a mucinous cystadenoma, one had a mucinous cystadenocarcinoma, and four had adenocarcinomas associated with cysts. CT identified a pancreatic cystic lesion in each patient. In all patients, ERCP showed either focal irregular narrowing, occlusion, or displacement of the main pancreatic duct at the corresponding location without the ductal changes of chronic pancreatitis. This helped to preoperatively differentiate these lesions from pseudocysts, hastening appropriate operation, obviating further testing and consultation, and aiding the intraoperative surgical strategy. 相似文献
10.
Ralls PW; Johnson MB; Kanel G; Dobalian DM; Colletti PM; Boswell WD Jr; Radin DR; Halls JM 《Radiology》1986,161(2):451-454
FM sonography - a signal-processing technique that uses frequency and phase information as well as amplitude data - shows promise in evaluation of patients with diffuse liver disease. In a prospective blinded review of 37 patients with biopsy-proved liver disease and 42 healthy volunteers, FM sonography was clearly superior to traditional amplitude-based (AM) sonography in distinguishing healthy from diseased subjects. Statistically significant differences were seen in accuracy (FM, 98.7%; AM, 84.8%), sensitivity (FM, 97.3%; AM, 70.3%), and negative predictive value (FM, 97.7%; AM, 78.8%). Our data also suggest that current FM sonographic techniques cannot differentiate among histologic findings associated with different hepatic parenchymal abnormalities. It is unclear, therefore, whether FM imaging can reduce the numbers of patients who require biopsy for diagnosis or the frequency of biopsy procedures in patients with known disease. 相似文献